MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
- Written by PR Newswire
- Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.
- The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity.
- More than 800 million people...
Read more: MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function














